Kim-Hafken Tina

Kim-Hafken Tina

Conseiller Juridique Général chez RAIN ONCOLOGY INC.

Health Technology
Consumer Services

Provenance du réseau au premier degré de Kim-Hafken Tina

EntitéType d'entitéIndustrie
Subsidiary Biotechnology 10

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Kim-Hafken Tina via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Medical Specialties

Lucio Tozzi

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Lucio Tozzi

Corporate Officer/Principal

College/University

Allan S. Wagman

Undergraduate Degree

Miscellaneous Commercial Services

Zack Malkin

Consultant / Advisor

The University of Texas at Austin College/University

Zack Malkin

Allan S. Wagman

Undergraduate Degree

Doctorate Degree

Investment Managers

Ryan Fukushima

Zack Malkin

Private Equity Investor

Private Equity Investor

University of Pennsylvania College/University

Robert Doebele

Doctorate Degree

Miscellaneous Commercial Services

Vijaya Tirunagaru

Corporate Officer/Principal

Sri Venkateswara University College/University

Vijaya Tirunagaru

Undergraduate Degree

Sri Krishnadevaraya University College/University

Vijaya Tirunagaru

Graduate Degree

Pharmaceuticals: Major

Vijaya Tirunagaru

Corporate Officer/Principal

SAGIMET BIOSCIENCES INC. Pharmaceuticals: Major

Allan S. Wagman

Corporate Officer/Principal

EIGER BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Erik Atkisson

Compliance Officer

Miscellaneous Commercial Services

Allan S. Wagman

Corporate Officer/Principal

University of Colorado Cancer Center College/University

Robert Doebele

Corporate Officer/Principal

CYTOKINETICS, INCORPORATED Pharmaceuticals: Major

Erik Atkisson

Compliance Officer

College/University

Erik Atkisson

Undergraduate Degree

The University of Edinburgh College/University

Erik Atkisson

Graduate Degree

Georgetown University Law Center College/University

Erik Atkisson

Graduate Degree

Middle Tennessee State University College/University

Charmi Turner

Undergraduate Degree

COHERUS BIOSCIENCES, INC. Pharmaceuticals: Major

Charmi Turner

Human Resources Officer

CORIUM INTERNATIONAL INC Pharmaceuticals: Major

Charmi Turner

Human Resources Officer

Princeton University College/University

Robert Doebele

Undergraduate Degree

Pharmaceuticals: Major

Nora Ku

Corporate Officer/Principal

Information Technology Services

Ryan Fukushima

Chief Operating Officer

LOXO ONCOLOGY INC Pharmaceuticals: Major

Nora Ku

Corporate Officer/Principal

Investment Managers

Ryan Fukushima

Corporate Officer/Principal

Investment Managers

Ryan Fukushima

Corporate Officer/Principal

Packaged Software

Ryan Fukushima

Corporate Officer/Principal

Investment Managers

Ryan Fukushima

Corporate Officer/Principal

Investment Managers

Ryan Fukushima

Corporate Officer/Principal

California Polytechnic State University (San Luis Obispo) College/University

Ryan Fukushima

Undergraduate Degree

Stephen M. Ross School of Business College/University

Ryan Fukushima

Masters Business Admin

Biotechnology

Ryan Fukushima

Founder

University of California, Los Angeles College/University

Nora Ku

Corporate Officer/Principal

University of Michigan College/University

Ryan Fukushima

Masters Business Admin

PROTAGONIST THERAPEUTICS, INC. Biotechnology

Lucio Tozzi

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Lucio Tozzi

Chief Tech/Sci/R&D Officer

Royal Holloway University of London College/University

Lucio Tozzi

Undergraduate Degree

PROKIDNEY CORP. Biotechnology

Lucio Tozzi

Chief Tech/Sci/R&D Officer

Investment Managers

Zack Malkin

Private Equity Investor

Statistiques

Internationale

Etats-Unis 38
Inde 4
Royaume-Uni 3

Sectorielle

Consumer Services 17
Health Technology 16
Finance 7
Commercial Services 4
Technology Services 3

Opérationnelle

Corporate Officer/Principal 20
Undergraduate Degree 8
Chief Tech/Sci/R&D Officer 7
Human Resources Officer 5
Graduate Degree 5
  1. Bourse
  2. Insiders
  3. Kim-Hafken Tina
  4. Connexions Sociétés
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT